DOXORUBICIN TEVA 2MG/ML INF CNC SOL 25ML
What is the maximum co-payment for DOXORUBICIN TEVA?
If the insurance company contributes, the maximum co-payment is 13,18 Kč. The maximum pharmacy price is 713,35 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but only during an outpatient procedure. When dispensed on prescription, the patient always pays the full price.
Does DOXORUBICIN TEVA have a counted co-payment set?
No, this medicine has no counted co-payment.
How much does the insurance company pay for one dispensed reimbursed pack?
700,17 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Rychlý přehled
| Dosage form | Solution concentrate infusion |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, ale pouze při ambulantním výkonu. Při výdeji na recept platí pacient vždy plnou cenu. Maximální doplatek: 13,18 Kč. Maximální cena: 713,35 Kč. |
| Kdo může předepsat | clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecologyhematology and transfusion medicine, pediatric oncology and hematology |
| Složení | More information about the composition can be found in the SPC, section 6.1. |
| Dostupnost / výpadek | Ukončeno The latest report from the manufacturer is from 29. 4. 2026. Výroba byla ukončena s platností od 29. 4. 2026. The manufacturer lists medicines with the following code as a potential substitute: 01581420204622020462601076810107682 |
| Kód SÚKL | 0139065 |
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe DOXORUBICIN TEVA?
- clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology
- hematology and transfusion medicine, pediatric oncology and hematology
What is the composition of DOXORUBICIN TEVA?
. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
- Documents could not be found v lokální importní databázi.
Which medicines are similar to DOXORUBICIN TEVA?
The medicine belongs to ATC group L01DB01. Název skupiny není v lokální importní databázi dostupný.
Who manufactures DOXORUBICIN TEVA?
Informace o výrobci není dostupná.
Is the medicine in shortage?
The latest report from the manufacturer is from 29. 4. 2026. Production was terminated with effect from 29. 4. 2026. The manufacturer lists medicines with the following code as a potential substitute:
What is the unique code for DOXORUBICIN TEVA?
The medicine has code 0139065. Code details can be found here.
How many packs of DOXORUBICIN TEVA were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of DOXORUBICIN TEVA were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 22. 06. 2026